Postop Pain Control in Hip Fracture Surgery: Fascia Iliaca Compartment Block Versus Fracture Block
Withdrawn before enrolling · Early Phase 1 · Has a placebo group
Conditions studied: Hip Fractures, Analgesia, Opioid Use, Pain, Postoperative
In brief
The investigators propose to investigate the effect of intraoperative FICB and intrafragmentary fracture blockade on postoperative pain and opiate consumption using a randomized controlled trial study design. There will be three treatment groups: (1) fascia iliaca compartment blockade administered after surgical fixation using the loss of resistance technique with 30cc 0.25% marcaine (2) intrafragmentary fracture block using fluoroscopy guidance after surgical fixation with 30cc 0.25% marcaine and (3) placebo group, with no intervention.
Key facts
- Study ID
- NCT04335461
- Run by
- Montefiore Medical Center
- People needed
- 0
- Starts
- 2021-08-05
- Expected to finish
- 2023-03-17
- Last updated by the study team
- 2023-07-13
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age 60 years or older
- low energy mechanism (i.e. mechanical or syncopal fall from ground level)
- extracapsular location as defined on AP and lateral radiographs of the hip
You may not qualify if…
- polytrauma patients with multiple injuries, high energy mechanisms (i.e. pedestrian struck, motor vehicle collision, fall from height)
- inability for the patient to consent for themselves
- pathologic fracture types (secondary to tumor or atypical fractures due to bisphosphonate use)
- intolerance or allergies to opioids or local anesthetics
Where it is running
- Jacobi Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.